Bill > HB2292

This bill addresses health insurance coverage for HIV prevention and treatment by requiring insurers and Medicaid plans to provide comprehensive coverage for HIV-related drugs and services with no out-of-pocket costs. Specifically, insurers offering health benefit plans must cover FDA-approved drugs for HIV prevention and treatment, along with associated services like office visits, testing, vaccinations, and monitoring, without imposing cost-sharing, coinsurance, or deductibles. The bill prohibits health insurers and coordinated care organizations from requiring prior authorization or step therapy for HIV drugs when a prescribing provider determines the medication is medically necessary. This means patients can more easily access HIV prevention medications like pre-exposure prophylaxis (PrEP) and treatment drugs without facing financial barriers or administrative hurdles. The bill applies to health benefit plans offered, renewed, or extended after its effective date, and aims to improve access to essential HIV-related healthcare services by removing potential obstacles to treatment and prevention.

Budget and Finance, Education, Health and Social Services

https://olis.oregonlegislature.gov/liz/2025R1/Measures/Overview/HB2292